Disruptive New Therapy

Our groundbreaking therapy utilizes patented medical device and AI-driven photonic systems technology to establish a new and novel combinational therapeutic approach to more effectively manage and treat patients with challenging mucosal lesions. We are collaborating with a leading cancer center for its development and clinical evaluation. A pilot clinical study is planned in 2026.